A detailed history of Investment Research & Advisory Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Investment Research & Advisory Group, Inc. holds 940 shares of NVO stock, worth $81,939. This represents 0.02% of its overall portfolio holdings.

Number of Shares
940
Previous 940 -0.0%
Holding current value
$81,939
Previous $111,000 27.93%
% of portfolio
0.02%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $11,436 - $15,223
112 Added 13.53%
940 $120,000
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $34,760 - $41,758
396 Added 91.67%
828 $85,000
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $19,643 - $43,100
216 Added 100.0%
432 $39,000
Q3 2021

Oct 07, 2021

BUY
$84.42 - $106.62 $18,234 - $23,029
216 New
216 $21,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Investment Research & Advisory Group, Inc. Portfolio

Follow Investment Research & Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Research & Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Investment Research & Advisory Group, Inc. with notifications on news.